Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD

This study has been terminated.
(The decision to terminate was completely related to efficacy and there were no safety concerns.)
Information provided by:
Pfizer Identifier:
First received: December 8, 2005
Last updated: July 20, 2007
Last verified: July 2007
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2006
  Estimated Primary Completion Date: No date given
No publications provided by Pfizer

Publications automatically indexed to this study by Identifier (NCT Number):